CD146 Promoter Polymorphism (rs3923594) Is Associated with Recurrence of Clear Cell Renal Cell Carcinoma in Chinese Population
Authors:
Open Access
- 1 January 2017
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 2017, 1-7
Abstract
Introduction. CD146 is a membrane signal receptor in tumor-induced angiogenesis. However, limited studies have focused on the CD146 promoter polymorphisms in clear cell renal cell carcinoma (ccRCC). Purpose. The purpose of this study was to investigate the association between polymorphisms located in the promoter region of the CD146 gene and characteristics of ccRCC in Chinese population. The association between the CD146 promoter polymorphisms and CD146 expression was also investigated in ccRCC. Materials and Methods. A total of 600 samples including 300 ccRCC patients and 300 healthy controls were collected for analysis of the CD146 promoter polymorphisms by direct sequence. The CD146 expressions were measured by qRT-PCR. Results. We had not found any significant differences in genotypic and allelic frequencies of CD146 promoter polymorphisms between ccRCC patients and controls. The rs3923594 was associated with stage and metastasis (300 cases) and recurrence (263 cases) of ccRCC in Chinese population. A significant association was also observed between the rs3923594 and CD146 expression (227 cases) in ccRCC. Conclusions. CD146 promoter polymorphisms were not associated with the risk of ccRCC in Chinese population. The rs3923594 was an independent predictor of recurrence in Chinese patients with localized ccRCC.Keywords
Funding Information
- Anhui Natural Science Foundation (1508085MH157)
This publication has 19 references indexed in Scilit:
- Quantification of peripheral blood CD133 mRNA in identifying metastasis and in predicting recurrence of patients with clear cell renal cell carcinomaUrologic Oncology: Seminars and Original Investigations, 2014
- Functional TLR5 Genetic Variants Affect Human Colorectal Cancer SurvivalCancer Research, 2013
- TheCASP8-652 6N Insertion/Deletion Promoter Polymorphism is Associated with Renal Cell Carcinoma Risk and MetastasisJournal of Urology, 2013
- CD146 is a potential marker for the diagnosis of malignancy in cervical and endometrial cancerOncology Letters, 2013
- A Functional Insertion/Deletion Polymorphism (-94 ins/del ATTG) in the Promoter Region of the NFKB1 Gene Is Related to the Risk of Renal Cell CarcinomaUrologia Internationalis, 2012
- CD146 is a coreceptor for VEGFR-2 in tumor angiogenesisBlood, 2012
- CD146 gene expression in clear cell renal cell carcinoma: a potential marker for prediction of early recurrence after nephrectomyInternational Urology and Nephrology, 2012
- Serum Carbonic Anhydrase 9 Level is Associated With Postoperative Recurrence of Conventional Renal Cell CancerJournal of Urology, 2008
- Interleukin-4 Promoter Polymorphisms: A Genetic Prognostic Factor for Survival in Metastatic Renal Cell CarcinomaJournal of Clinical Oncology, 2007
- Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinomaCancer, 2005